In addition, through a network pharmacology approach, we identified 126 potential therapeutic targets, the enrichment analysis of which suggested that QR may exert anti-RSV and anti-inflammatory effects in vivo mainly by regulating the lipid and atherosclerosis, Kaposi's sarcoma-associated herpesvirus infection, and the AGE-RAGE signaling pathways. The gene discussed is RENBP; the disease is atherosclerosis.